Literature DB >> 19046710

A patient with hyper-IgD syndrome responding to simvastatin treatment.

H Attout1, S Guez, I Ranaivo, N Jameerbaccus, C Series.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19046710     DOI： 10.1016/j.ejim.2008.04.009

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN： 0953-6205            Impact factor:   4.487


× No keyword cloud information.
  4 in total

Review 1.  Autoinflammation: From monogenic syndromes to common skin diseases.

Authors:  Tien V Nguyen; Edward W Cowen; Kieron S Leslie
Journal:  J Am Acad Dermatol       Date:  2013-02-28       Impact factor: 11.527

2.  Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy.

Authors:  Lihi Atzmony; Young H Lim; Claire Hamilton; Jonathan S Leventhal; Annette Wagner; Amy S Paller; Keith A Choate
Journal:  J Am Acad Dermatol       Date:  2019-08-23       Impact factor: 11.527

Review 3.  Periodic Fever syndromes.

Authors:  Zachary Jacobs; Christina E Ciaccio
Journal:  Curr Allergy Asthma Rep       Date:  2010-11       Impact factor: 4.806

4.  Alendronate, a double-edged sword acting in the mevalonate pathway.

Authors:  Paola Maura Tricarico; Martina Girardelli; Giulio Kleiner; Alessandra Knowles; Erica Valencic; Sergio Crovella; Annalisa Marcuzzi
Journal:  Mol Med Rep       Date:  2015-06-18       Impact factor: 2.952
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.